Matthes KL, Limam M, Pestoni G, Held L, Korol D, Rohrmann S.
Impact of comorbidities at diagnosis on prostate cancer treatment and survival.
J Cancer Res Clin Oncol. 2018 Feb 7. doi: 10.1007/s00432-018-2596-6 [Epub ahead of print].

Adam S, Feller A, Rohrmann S, Arndt V.
Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.
Health Qual Life Outcomes. 2018 Jan 23;16(1):22. doi: 10.1186/s12955-017-0836-0.


Richard A, Faeh D, Bopp M, Rohrmann S.
Diet and Other Lifestyle Factors Associated with Prostate Cancer Differ Between the German and Italian Region of Switzerland.
Int J Vitam Nutr Res. 2017 Dec 8:1-8. doi: 10.1024/0300-9831/a000433. [Epub ahead of print].

Wanner M, Richard A, Matthes K, Ortelli L, Lorez M, Korol D, Bordoni A, Rohrmann S.
Trends in prostate cancer incidence between 1996 and 2013 in two Swiss regions by age, grade, and T-stage.
Cancer Causes & Control. 2017 Dec 4. doi: 10.1007/s10552-017-0993-9.

Van Hemelrijck M, Karagiannis SN, Rohrmann S.
Atopy and prostate cancer: Is there a link between circulating levels of IgE and PSA in humans?
Eur Heart J Acute Cardiovasc Care. 2017 Sep 1:2048872617729636. doi: 10.1177/2048872617729636 [Epub ahead of print].

Rohrmann S, Witassek F, Erne P, Rickli H, Radovanovic D.
Treatment of patients with myocardial infarction depends on history of cancer.
Eur Heart J Acute Cardiovasc Care. 2017 Sep 1:2048872617729636. doi: 10.1177/2048872617729636 [Epub ahead of print].

Lorez M, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Dehler S, Frick H, Konzelmann I, Maspoli M, Mousavi SM, Rohrmann S, Arndt V.
Evaluation of completeness of case ascertainment in Swiss cancer registration.
Eur J Cancer Prev. 2017 Sep;26 Joining forces for better cancer registration in Europe:S139-S146. doi: 10.1097/CEJ.0000000000000380.

Rohrmann S, Cabaset S, Linseisen J.
Fleischkonsum und Krebsrisiko – darf man noch Fleisch essen?
Praxis (Bern 1994). 2017 Aug;106(16):871-876. doi: 10.1024/1661-8157/a002747.

El Saadany T, Richard A, Wanner M, Rohrmann S.
Sex-specific effects of leisure-time physical activity on cause-specific mortality in NHANES III.
Prev Med. 2017 Aug;101:53-59. doi: 10.1016/j.ypmed.2017.05.029. Epub 2017 Jun 1.

Smith K, Byrne1, Castaño JM, Chirlaque MD, Lilja H, Agudo A, Ardanaz E, Rodríguez-Barranco M, Boeing H, Kaaks R, Khaw KT, Larrañaga N, Navarro C, Olsen A, Overvad K, Perez-Cornago A, Rohrmann S, Sánchez MJ, Tjønneland A, Tsilidis KK, Johansson M, Riboli E, Key TJ, Travis RC.
Vasectomy and Prostate Cancer Risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC).
J Clin Oncol. 2017 Apr 20;35(12):1297-1303. doi: 10.1200/JCO.2016.70.0062. Epub 2017 Mar 6.

Matthes KL, Limam M, Dehler S, Korol D, Rohrmann S.
Primary Treatment Choice Over Time and Relative Survival of Prostate Cancer Patients: Influence of Age, Grade, and Stage.
Oncol Res Treat. 2017;40(9):484-489. doi: 10.1159/000477096. Epub 2017 Aug 17.

Wanner M, Richard A, Martin B, Faeh D, Rohrmann S.
Associations between self-reported and objectively measured physical activity, sedentary behavior and overweight/obesity in NHANES 2003-2006.
Int J Obes (Lond). 2017 Jan;41(1):186-193. doi: 10.1038/ijo.2016.168. Epub 2016 Sep 28.


Minini R, Rohrmann S, Braun R, Korol D, Dehler S.
Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the canton of Zurich, Switzerland.
Melanoma Res. 2016 Dec 6. [Epub ahead of print]

Beleut M, Soeldner R, Egorov M, Guenther R, Dehler S, Morys-Wortmann C, Moch H, Henco K, Schraml P.
Discretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer Types.
PLoS One. 2016 Aug 18;11(8):e0161514. doi: 10.1371/journal.pone.0161514.

Oberli LS, Valeri F, Korol D, Rohrmann S, Dehler S.
31 years of lung cancer in the canton of Zurich, Switzerland: incidence trends by sex, histology and laterality.
Swiss Med Wkly. 2016 Jul 11;146:w14327. doi: 10.4414/smw.2016.14327.

Ernst J, Ikenberg K, Apel B, Schumann DM, Huber G, Studer G, Rordorf T, Riesterer O, Rössle M, Korol D, Bredell MG.
Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.
Oncotarget. 2016 Nov 15;7(46):76151-76158. doi: 10.18632/oncotarget.12691.

Rössle M, Cathomas G, Bonapace L, Sachs M, Dehler S, Storz M, Huber G, Moch H, Junt T, Mertz KD.
Interleukin-33 Expression Indicates a Favorable Prognosis in Malignant Salivary Gland Tumors.
Int J Surg Pathol. 2016 Aug ;24(5):394-400. ; doi: 10.1177/1066896916633856.

Gramatzki D, Dehler S, Rushing EJ, Zaugg K, Hofer S, Yonekawa Y, Bertalanffy H, Valavanis A, Korol D, Rohrmann S, Pless M, Oberle J, Roth P, Ohgaki H, Weller M.
Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009.
Cancer. 2016 Jul 15;122(14):2206-15. doi: 10.1002/cncr.30023. Epub 2016 Apr 18.

Gugger A, Barnhill RL, Seifert B, Dehler S, Moch H, Lugassy C, Marques-Maggio E, Rushing EJ, Mihic-Probst D.
Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations.
PLoS One. 2016 May 23;11(5):e0156115. doi: 10.1371/journal.pone.0156115.

Clifford GM, Franceschi S, Keiser O, Schöni-Affolter F, Lise M, Dehler S, Levi F, Mousavi M, Bouchardy C, Wolfensberger A, Darling KE, Staehelin C, Bertisch B, Kuenzli E, Bernasconi E, Pawlita M, Egger M.
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.
Int J Cancer. 2016 Apr 1; 138(7):1732-40. doi: 10.1002/ijc.29913 .

Christen S, Vetsch J, Mader L, Dehler S, Korol D, Kuehni C, Rueegg CS, Michel G.
Preferences for the organization of long-term follow-up in adolescent and young adult cancer survivors.
Supportive Care in Cancer J. 2016 Mar 18.

Matter-Walstra KW, Achermann R, Rapold R, Klingbiel D, Bordoni A, Dehler S, Konzelmann I, Mousavi M, Clough-Gorr KM, Szucs T, Schwenkglenks M, Pestalozzi BC.
Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09).
Eur J Cancer Care (Engl). 2016 Feb 9. doi: 10.1111/ecc.12453. 



Feller A, Fehr M, Bordoni A, Bouchardy C, Frick H, Mousavi M, Steiner A, Arndt V, Clough-Gorr KM; Nicer Working Group.
Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011.
Swiss Med Wkly. November 2015, Dec 10, doi: 10.4414/smw.2015.14245.

Pomp V, Leo C, Mauracher A, Korol D, Guo W, Varga Z.
Differential expression of epithelial-mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer.
Breast Cancer Research and Treatment. November 2015, Volume 154, Issue 1, pp 45-55
Epub 2015 Oct 14. 

Thies S, Friess M, Frischknecht L, Korol D, Felley-Bosco E, Stahel R, Vrugt B, Weder W, Opitz I, Soltermann A.
Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis.
PLoS One. 2015 Sep 30;10(9):e0139312. doi: 10.1371/journal.pone.0139312. eCollection 2015.

Prater J, Valeri F, Korol D, Rohrmann S, Dehler S.
Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.
J Cancer Res Clin Oncol. 2015 Aug 23. 

Steliarova-Foucher E, Stiller C, Colombet M, Kaatsch P, Zanetti R, Peris-Bonet R.
Registration of childhood cancer: Moving towards pan-European coverage?
Eur J Cancer. 2015 Apr 17. pii: S0959-8049(15)00225-7. doi: 10.1016/j.ejca.2015.03.009. 

Pflueger D, Mittmann C, Dehler S, Rubin M, Moch H, Schraml P.
Functional characterization of BC039389-GATM and KLK4-KRSP1 chimeric read-through transcripts which are up-regulated in renal cell cancer.
BMC Genomics 2015 Mar 27, 16:247 doi:10.1186/s12864-015-1446-z 

Bieri U, Moch H, Dehler S, Korol D, Rohrmann S.
Changes in autopsy rates among cancer patients and their impact on cancer statistics from a public health point of view: a longitudinal study from 1980 to 2010 with data from Cancer Registry Zurich.
Virchows Arch. 2015 Mar 7, doi:10.1007/s00428-015-1734-7 

Matter-Walstra KW, Achermann R, Rapold R, Klingbiel D, Bordoni A, Dehler S, Jundt G, Konzelmann I, Clough-Gorr K, Szucs T, Pestalozzi BC, Schwenkglenks M.
Cancer-Related Therapies at the End of Life in Hospitalized Cancer Patients from Four Swiss Cantons: SAKK 89/09.
Oncology.2015;88(1):18-27. doi: 10.1159/000367629. Epub 2014 Sep 26.

Hitz F, Arndt V, Lorez M, and the NICER Working Group.
Survival Trends for non-Hodgkin lymphoma patients in Switzerland.
Schweizer Krebsbulletin 1/2015, 61-66.

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo E Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; the CONCORD Working Group.
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Lancet, 2014 Nov 26. pii: S0140-6736(14)62038-9. doi: 10.1016/S0140-6736(14)62038-9.

Alexandre Bodmer, Anita Feller, Andrea Bordoni, Christine Bouchardy, Silvia Dehler, Silvia Ess, Fabio Levi, Isabelle Konzelmann, Elisabetta Rapiti, Annik Steiner, Kerri M. Clough-Gorr, the NICER Working Group
Breast cancer in younger women in Switzerland 1996–2009: A longitudinal population-based study.
The Breast, 2014.

Dehler S, Tonev S, Korol D, Rohrmann S, Dimitrova N.
Recent trends in cancer incidence: impact of risk factors, diagnostic activities and data quality of registration.
Tumori. 2014 Jul-Aug;100(4):399-405. doi: 10.1700/1636.17894.

Van Hemelrijck M, Feller A, Garmo H, Valeri F, Korol D, Dehler S, Rohrmann S.
Incidence of second malignancies for prostate cancer.
PLoS One. 2014 Jul 21;9(7):e102596. doi: 10.1371/journal.pone.0102596. eCollection 2014.

Matter-Walstra KW, Achermann R, Rapold R, Klingbiel D, Bordoni A, Dehler S, Jundt G, Konzelmann I, Clough-Gorr KM, Szucs TD, Schwenkglenks M, Pestalozzi BC.
Delivery of health care at the end of life in cancer patients of four swiss cantons: a retrospective database study (SAKK 89/09).
BMC Cancer. 2014 May 1;14:306. doi: 10.1186/1471-2407-14-306.

Thomas Ruhstaller, Volker Arndt, Matthias Lorez and the NICER Working Group
Trends in survival from oesophageal cancer in Switzerland (PDF).
Schweizer Krebs Bulletin 3-2014

Viola Heinzelmann-Schwarz, Matthias Lorez and the NICER Working Group
Trends in Survival from Cancer of the Corpus uteri in Switzerland (PDF).
Schweizer Krebs Bulletin 2-2014

Jean-Francois Dufour, Andrea Bordoni, Matthias Lorez and the NICER Working Group
Trends in Hepatic Cancer Survival in Switzerland (PDF).
Schweizer Krebs Bulletin 1-2014


Bertisch B, Franceschi S, Lise M, Vernazza P, Keiser O, Schöni-Affolter F, Bouchardy C, Dehler S, Levi F, Jundt G, Ess S, Pawlita M, Kovari H, Wandeler G, Calmy A, Cavassini M, Stöckle M, Clifford G; Swiss HIV Cohort Study Investigators.
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study.
Am J Epidemiol. 2013 Sep 15;178(6):877-84. doi: 10.1093/aje/kwt153. Epub 2013 Jul 30.

Tinguely M, Thies S, Frigerio S, Reineke T, Korol D, Zimmermann DR.
IRF8 is associated with germinal center B-cell-like type of diffuse large B-cell lymphoma and exceptionally involved in translocation t(14;16)(q32.33;q24.1).
Leuk Lymphoma. 2013 Jun 12. [Epub ahead of print]

Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R; the EUROCARE Working Group.
Cancer prevalence estimates in Europe at the beginning of 2000.
Ann Oncol. 2013 Apr 3. [Epub ahead of print]

Zimmermann AK, Imig J, Klar A, Renner C, Korol D, Fink D, Stadlmann S, Singer G, Knuth A, Moch H, Caduff R.
Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas.
Virchows Arch. 2013 May;462(5):565-74. doi: 10.1007/s00428-013-1395-3. Epub 2013 Mar 26.

Montemurro M, Lorez M, NICER Working Group.
Trends in pancreatic cancer survival in Switzerland (PDF).
Schweizer Krebsbulletin 2013(4).

Spitale A, Feller A, Lorez M, NICER Working Group.
Trends in stomach cancer survival in Switzerland (PDF).
Schweizer Krebsbulletin 2013(3).

C. Bouchardy, M. Lorez, K. Clough-Gorr, NICER Working Group.
Trends in Bladder Cancer survival in Switzerland (PDF).
Schweizer Krebsbulletin 2013(2).

Dehler S, Rohrmann S, Lorez M, Clough-Gorr K, NICER Working Group.
Trends in prostate cancer survival in Switzerland (PDF).
Schweizer Krebsbulletin 2013(1).

Soldini D, Montagna C, Schüffler P, Martin V, Georgis A, Thiesler T, Curioni-Fontecedro A, Went P, Bosshard G, Dehler S, Mazzuchelli L, Tinguely M.
A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome.
Ann Oncol. 2013 Jan;24(1):193-201. doi: 10.1093/annonc/mds209. Epub 2012 Sep 11.


Bordoni A, Lorez M, Bouchardy C, Camey B, Betticher D, Dehler S, Gautschi O, Konzelmann I, Clough-Gorr K, NICER Working Group.
Trends in Lung Cancer Survival in Switzerland (PDF).
Schweizer Krebsbulletin 2012(3):240-244.

M. Joerger, B. Thürlimann, A. Savidan, H. Frick, C. Rageth, U. Lütolf, G. Vlastos, C. Bouchardy, I. Konzelmann, A. Bordoni, N. Probst-Hensch, G. Jundt, S. Ess.
Treatment of breast cancer in the elderly: A prospective, population-based Swiss study
J Geriatr Oncol (2012)

Elodie Roy, Natascha Wyss.
Hautmelanom: Bestandesaufnahme und Prävention.
Bundesamt für Statistik BFS, BFS Aktuell, 14 Gesundheit, Neuchâtel, 16.04.2012.

Joerger M, Thürlimann B, Savidan A, Frick H, Bouchardy C, Konzelmann I, Probst-Hensch N, Ess S.
A population-based study on the implementation of treatment recommendations for chemotherapy in early breast cancer.
Clin Breast Cancer. 2012 Apr;12(2):102-9. Epub 2011 Dec 3.

Joerger M, Ess S, Dehler S, Savidan A, Bouchardy C, Frick H, Konzelmann I, Thürlimann B.
A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer.
Swiss Med Wkly. 2012 Apr 11;142:0. doi: 10.4414/smw.2012.13571.

Aigner F, Korol D, Schmitt AM, Kurrer MO.
Extranodal diffuse large B cell lymphoma of cutaneous follicle centre lymphoma type: a study of 24 patients with non-cutaneous primary limited stage extranodal diffuse large B cell lymphoma in support of a new concept.
Histopathology. 2012 Apr;60(5):774-84. doi: 10.1111/j.1365-2559.2011.04122.x. Epub 2012 Feb 3.

Clifford GM, Lise M, Franceschi S, Egger M, Bouchardy C, Korol D, Levi F, Ess S, Jundt G, Wandeler G, Fehr J, Schmid P, Battegay M, Bernasconi E, Cavassini M, Calmy A, Keiser O, Schöni-Affolter F; the Swiss HIV Cohort Study.
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection.
Br J Cancer. 2012 Jan 31;106(3):447-452. doi: 10.1038/bjc.2011.558. Epub 2012 Jan 12.


Butsch R, Lukas Waelti S, Schaerer S, Braun J, Korol D, Probst-Hensch N, Moch H, Kurrer M.
Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma.
Leuk Lymphoma. 2011 Jul;52(7):1230-8. Epub 2011 May 23.

Ess S, Joerger M, Frick H, Probst-Hensch N, Vlastos G, Rageth C, Lütolf U, Savidan A, Thürlimann B.
Predictors of state-of-the-art management of early breast cancer in Switzerland.
Ann Oncol. 2011 Mar;22(3):618-24. Epub 2010 Aug 12.


Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W.
Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Hum Pathol. 2010 Nov;41(11):1558-65.

Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, Bouchardy C, Dehler S, Jundt G, Ess S, Bordoni A, Konzelmann I, Frick H, Dal Maso L, Elzi L, Furrer H, Calmy A, Cavassini M, Ledergerber B, Keiser O; Swiss HIV Cohort Study.
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
Br J Cancer. 2010 Jul 27;103(3):416-22. Epub 2010 Jun 29.

Albinger-Hegyi A, Stoeckli SJ, Schmid S, Storz M, Iotzova G, Probst-Hensch NM, Rehrauer H, Tinguely M, Moch H, Hegyi I.
Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC).
Int J Cancer. 2010 Jun 1;126(11):2653-62.

Riener MO, Fritzsche FR, Soll C, Pestalozzi BC, Probst-Hensch N, Clavien PA, Jochum W, Soltermann A, Moch H, Kristiansen G.
Expression of the extracellular matrix protein periostin in liver tumours and bile duct carcinomas.
Histopathology. 2010 Apr;56(5):600-6.

Leuenberger M, Frigerio S, Wild PJ, Noetzli F, Korol D, Zimmermann DR, Gengler C, Probst-Hensch NM, Moch H, Tinguely M.
AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations.
Mod Pathol. 2010 Feb;23(2):177-86. Epub 2009 Nov 6.

Deglise C, Bouchardy C, Burri M, Usel M, Neyroud-Caspar I, Vlastos G, Chappuis PO, Ceschi M, Ess S, Castiglione M, Rapiti E, Verkooijen HM.
Impact of obesity on diagnosis and treatment of breast cancer.
Breast Cancer Res Treat. 2010 Feb;120(1):185-93. Epub 2009 Jul 14.

Probst-Hensch NM, Steiner JH, Schraml P, Varga Z, Zürrer-Härdi U, Storz M, Korol D, Fehr MK, Fink D, Pestalozzi BC, Lütolf UM, Theurillat JP, Moch H.
IGFBP2 and IGFBP3 Protein Expressions in Human Breast Cancer: Association with Hormonal Factors and Obesity.
Clin Cancer Res. 2010 Feb 1;16(3):1025-1032. Epub 2010 Jan 26.

Adam M, Weid NV, Michel G, Zwahlen M, Lutz JM, Probst-Hensch N, Niggli F, Kuehni C. for the Swiss Pediatric Oncology Group (SPOG)
Dr. med. R. Angst, Aarau; Prof. Dr. med. M. Paulussen, V. Stahel, Basel; Prof. Dr. med A. Hirt, K. Zimmermann, Bern; PD Dr. med A. H. Ozsahin, M. Berner, Geneva; PD Dr. med. N. von der Weid, PD Dr. med. M. Beck Popovic, Dr. med. E. Garcia, Lausanne; Dr. med. L. Nobile Buetti, Locarno; Dr. med. U. Caflisch, Y. Bonetti, Lucerne; Dr. med. J. Greiner, F. Hochreutener, St. Gallen; Prof. Dr. med. F. Niggli, H. Markiewicz, Zurich.
for the Swiss Association of Cancer Registries (ASRT)
Prof. Dr. G. Jundt, Basel City & Land; Dr. J.‐M. Lutz, Prof. Dr. C. Bouchardy, P. Pury, G. Fioretta, M. Usel, Geneva; Dr. H. Frick, A.‐M. Abutillo, Grisons & Glarus; Prof. Dr. F. Levi, Neuchatel; Dr. S. Ess, St. Gallen & Appenzell; Dr. A. Bordoni, A. Spitale, Ticino; Dr. D. De Weck, Dr. I. Konzelmann, Valais; Prof. Dr. F. Levi, Vaud; Prof. Dr. N. Probst, Dr. A. Kofler, Zurich.
Access to specialized pediatric cancer care in Switzerland.
Pediatr Blood Cancer. 2010 Jan 27. 


Bordoni A, Probst-Hensch NM, Mazzucchelli L, Spitale A.
Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study.
Br J Cancer. 2009 Dec 1;101(11):1925-31

Riener MO, Fritzsche FR, Clavien PA, Pestalozzi BC, Probst-Hensch N, Jochum W, Kristiansen G.
IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas.
Hum Pathol. 2009 Oct;40(10):1377-83

Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Müllhaupt B, Clavien PA, Bahra M, Neuhaus P, Wild P, Fritzsche F, Moch H, Jochum W, Kristiansen G.
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.
Hepatology. 2009 May;49(5):1602-9


Soltermann A, Tischler V, Arbogast S, Braun J, Probst-Hensch N, Weder W, Moch H, Kristiansen G.
Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
Clin Cancer Res. 2008 Nov 15;14(22):7430-7.

Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, Rauch A, Probst-Hensch NM, Bouchardy C, Levi F, Franceschi S; Swiss HIV Cohort.
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
AIDS. 2008 Oct 18;22(16):2135-41.

Umbehr M, Kessler TM, Sulser T, Kristiansen G, Probst N, Steurer J, Bachmann LM.
ProCOC: the prostate cancer outcomes cohort study.
BMC Urol. 2008 Jun 17;8:9.

Tinguely M, Jenni B, Knights A, Lopes B, Korol D, Rousson V, Curioni Fontecedro A, Cogliatti SB, Bittermann AG, Schmid U, Dommann-Scherrer C, Maurer R, Renner C, Probst-Hensch NM, Moch H, Knuth A, Zippelius A.
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome.
Cancer Sci. 2008 Apr;99(4):720-5. Epub 2008 Feb 27

Opitz I, Soltermann A, Abaecherli M, Hinterberger M, Probst-Hensch N, Stahel R, Moch H, Weder W.
PTEN expression is a strong predictor of survival in mesothelioma patients.
Eur J Cardiothorac Surg. 2008 Mar;33(3):502-6. Epub 2008 Jan 8.

Polesel J, Clifford GM, Rickenbach M, Dal Maso L, Battegay M, Bouchardy C, Furrer H, Hasse B, Levi F, Probst-Hensch NM, Schmid P, Franceschi S; Swiss HIV Cohort Study.
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
AIDS. 2008 Jan 11;22(2):301-6.


Schmitt AM, Anlauf M, Rousson V, Schmid S, Kofler A, Riniker F, Bauersfeld J, Barghorn A, Probst-Hensch NM, Moch H, Heitz PU, Kloeppel G, Komminoth P, Perren A.
WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors.
Am J Surg Pathol. 2007 Nov;31(11):1677-82. 

Tinguely M, Jenni B, Reineke T, Korol D, Kofler A, Rousson V, Dommann-Scherrer C, Maurer R, Moch H, Probst-Hensch NM.
Chromosomal Translocations t(4;14), t(11;14) and Proliferation Rate Stratify Patients With Mature Plasma Cell Myelomas Into Groups With Different Survival Probabilities-A Molecular Epidemiologic Study on Tissue Microarrays.
Am J Surg Pathol. 2007 May;31(5):690-696.

Theurillat JP, Zurrer-Hardi U, Varga Z, Storz M, Probst-Hensch NM, Seifert B, Fehr MK, Fink D, Ferrone S, Pestalozzi B, Jungbluth AA, Chen YT, Jager D, Knuth A, Moch H.
NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
Cancer Immunol Immunother. 2007 Apr 5

Ceschi M, Gutzwiller F, Moch H, Eichholzer M, Probst-Hensch N.
Epidemiology and pathophysiology of obesity as cause of cancer.
Swiss Med Wkly. 2007 Jan 27;137(3-4):50-6.


Franceschi S, Polesel J, Rickenbach M, Dal Maso L, Probst-Hensch NM, Fux C, Cavassini M, Hasse B, Kofler A, Ledergerber B, Erb P, Clifford GM.
Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV Cohort Study.
Br J Cancer. 2006 Nov 14


Fisch T, Pury P, Probst N, Bordoni A, Bouchardy C, Frick H, Jundt G, De Weck D, Perret E, Lutz JM.
Variation in survival after diagnosis of breast cancer in Switzerland.
Ann Oncol. 2005 Dec;16(12):1882-8. Epub 2005 Oct 10.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort.
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.


Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P.
Genetic pathways to glioblastoma: a population-based study.
Cancer Res. 2004 Oct 1;64(19):6892-9.

Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schüler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H.
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
Acta Neuropathol. 2004 Jul;108(1):49-56. Epub 2004 Apr 28.

Zwahlen M, Bopp M, Probst-Hensch NM.
Mammography screening in Switzerland: limited evidence from limited data.
Swiss Med Wkly. 2004 May 29;134(21-22):295-306


Burkhard C, Di Patre PL, Schüler D, Schüler G, Yaşargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H.
A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma.
J Neurosurg. 2003 Jun;98(6):1170-4.

Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, Strnad M, Jechov'a M, Storm HH, Aareleid T, Hakulinen T, Velten M, Lef'evre H, Danzon A, Buemi A, Daur'es JP, Ménégoz F, Raverdy N, Sauvage M, Ziegler H, Comber H, Paci E, Vercelli M, De Lisi V, Tumino R, Zanetti R, Berrino F, Stanta G, Langmark F, Rachtan J, Mezyk R, Blaszczyk J, Ivan P, Primic-Zakelj M, Martínez AC, Izarzugaza I, Borràs J, Garcia CM, Garau I, Sánchez NC, Aicua A, Barlow L, Torhorst J, Bouchardy C, Levi F, Fisch T, Probst N, Visser O, Quinn M, Gavin A, Brewster D, Mikov M; ENCR Working Group.
Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends.
Cancer Causes Control. 2003 Oct;14(8):791-803. Erratum in: Cancer Causes Control. 2004 Feb;15(1):103.

Publications from 1991 until 2002 (PDF)


We use cookies to make our website user-friendly, to continuously improve it and to analyze the traffic of our website. By continuing to browse the site, you are agreeing to our use of cookies. Further information can be found in our privacy policy.